CD276 and acute myeloid leukemia: We detected an overall high level of B7-H3 expression in approximately two-thirds of all patient samples tested, with heterogeneity depending on the ELN risk group, genetic background as well as the lineage of origin of the AML blasts (i.e., FAB subgroup).